South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dr reddyÆs laboratories (pty) ltd - capsules - see ingredients - each capsule contains omeprazole 10,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dr reddyÆs laboratories (pty) ltd - capsules - see ingredients - each capsule contains omeprazole 20,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dr reddyÆs laboratories (pty) ltd - capsules - see ingredients - each capsule contains omeprazole 40,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dr reddyÆs laboratories (pty) ltd - powder - 100,0 mg - each vial contains azacitidine 100,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dr reddyÆs laboratories (pty) ltd - tablet - not indicated - none

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dr reddyÆs laboratories (pty) ltd - injection - see ingredients - each vial contains esomeprazole 40,0 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - teriflunomide, quantity: 14 mg - tablet - excipient ingredients: maize starch; magnesium stearate; hyprolose; silicon dioxide; lactose monohydrate; sodium starch glycollate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; indigo carmine aluminium lake - teriflunomide dr.reddy's is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - posaconazole, quantity: 100 mg - tablet, modified release - excipient ingredients: croscarmellose sodium; macrogol 400; hypromellose acetate succinate; silicon dioxide; triacetin; purified talc; hyprolose; iron oxide red; magnesium stearate; titanium dioxide; microcrystalline cellulose; hypromellose - posaconazole dr.reddy's (posaconazole) is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: ,? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ,? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy. ,posaconazole dr.reddy's is also indicated for the: ,? prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dr reddyÆs laboratories (pty) ltd - tablet - see ingredients - each tablet contains tranexamic acid 500,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dr reddyÆs laboratories (pty) ltd - tablet - see ingredients - each tablet contains desloratadine 5,0 mg